Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $54.0 million.

  • Orchestra BioMed Holdings' Shares Outstanding (Weighted Average) rose 42.65% to $54.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.0 million, marking a year-over-year increase of 42.65%. This contributed to the annual value of $38.0 million for FY2024, which is 6.35% up from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Shares Outstanding (Weighted Average) stood at $54.0 million for Q3 2025, which was down 0.00% from $54.0 million recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Shares Outstanding (Weighted Average) registered a high of $54.0 million during Q2 2025, and its lowest value of $11.2 million during Q3 2022.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $39.2 million, with a median of $35.8 million in 2024.
  • Data for Orchestra BioMed Holdings' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 218.80% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Orchestra BioMed Holdings' Shares Outstanding (Weighted Average) stood at $30.6 million in 2022, then rose by 16.69% to $35.7 million in 2023, then increased by 6.35% to $38.0 million in 2024, then soared by 42.65% to $54.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $54.0 million in Q3 2025, compared to $54.0 million in Q2 2025 and $38.3 million in Q1 2025.